NCT05300087View on ClinicalTrials.gov

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

April 25, 2022

Study Completion Date

April 26, 2022

Conditions
Healthy
Interventions
DRUG

Albuterol Sulfate Inhalation Aerosol 108mcg per actuation

MDI, 2 puffs, single dose, fasting

DRUG

Proair HFA (albuterol sulfate) Inhalation Aerosol 90mcg per actuation

MDI, 2 puffs, single dose, fasting

Trial Locations (1)

251

Tamshui Mackay Memorial Hospital, New Taipei City

Sponsors
All Listed Sponsors
lead

Intech Biopharm Ltd.

INDUSTRY

NCT05300087 - Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter